Evidence map›Paper›PMID 38543243›Full record

ArticlePharmaceutics2024

Integrated QSAR Models for Prediction of Serotonergic Activity: Machine Learning Unveiling Activity and Selectivity Patterns of Molecular Descriptors.

Natalia Łapińska, Adam Pacławski, Jakub Szlęk, Aleksander Mendyk

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Explainable Artificial Intelligence (xAI) for 5-HTMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Explainable Artificial Intelligence in the Field of Drug Research.Drug design, development and therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalia ŁapińskaDepartment of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.ORCID 0000-0001-6660-4446
Adam PacławskiDepartment of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.ORCID 0000-0003-2801-6197
Jakub SzlękDepartment of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.ORCID 0000-0003-1537-9650
Aleksander MendykDepartment of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, 30-688 Kraków, Poland.ORCID 0000-0002-4394-9115

Funding

"Excellence Initiative-Research University" at Jagiellonian University qLIFE Priority Research AreaJagiellonian University N42/DBS/000261Smart Growth Operational Programme POIR 4.2 POIR.04.02.00-00-D023/20
6 · The paper itself

Abstract

Understanding the features of compounds that determine their high serotonergic activity and selectivity for specific receptor subtypes represents a pivotal challenge in drug discovery, directly impacting the ability to minimize adverse events while maximizing therapeutic efficacy. Up to now, this process has been a puzzle and limited to a few serotonergic targets. One approach represented in the literature focuses on receptor structure whereas in this study, we followed another strategy by creating AI-based models capable of predicting serotonergic activity and selectivity based on ligands' representation by molecular descriptors. Predictive models were developed using Automated Machine Learning provided by Mljar and later analyzed through the SHAP importance analysis, which allowed us to clarify the relationship between descriptors and the effect on activity and what features determine selective affinity for serotonin receptors. Through the experiments, it was possible to highlight the most important features of ligands based on highly efficient models. These features are discussed in this manuscript. The models are available in the additional modules of the SerotoninAI application called "Serotonergic activity" and "Selectivity".

Indexed as

machine learningmolecular descriptorsMordredselectivity and activityserotonin receptorsstatistical analysis

Identifiers

PMID38543243
PMCPMC10974160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.